BACKGROUND: Serum measurements of cytokines, mediators of various B and T cell activities, are important markers of inflammation and immune dysregulation. We assessed the reproducibility of serum cytokine measurements over a five-year period among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). METHODS: Levels of 13 cytokines [interleukin (IL) 1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, interferon-gamma (IFNγ), granulocyte macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-α (TNFα)] in stored sera from three collections (study baseline,+1 year, and+5 years) among 28 randomly selected PLCO participants were measured using a high-sensitivity Luminex xMap-based multiplex panel. Within- and between-subject components of variance were estimated from random effects models and were used to calculate the coefficient of variation (CV) and intraclass correlation coefficient (ICC) for analytes with <30% of samples below the limit of detection (LOD). Spearman correlation coefficients between measurements of the same analyte over time and between analytes were also calculated. RESULTS: Among the six cytokines with <30% of samples below the LOD, we observed excellent reproducibility for IL-6, IL-7, IL-13, and TNFα (ICC≥0.73), and fair to good reproducibility for IL-8 (ICC=0.55) and IL-10 (ICC=0.60). Spearman correlation coefficients comparing paired measurements of each cytokine at baseline and at +5 years were high (ρ≥0.74) with the exception of IL-10 (ρ=0.44). CONCLUSIONS: These results suggest that measurements of most of the cytokines evaluated in this study were highly reproducible over five-year periods. Published by Elsevier Ltd.
BACKGROUND: Serum measurements of cytokines, mediators of various B and T cell activities, are important markers of inflammation and immune dysregulation. We assessed the reproducibility of serum cytokine measurements over a five-year period among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). METHODS: Levels of 13 cytokines [interleukin (IL) 1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, interferon-gamma (IFNγ), granulocyte macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-α (TNFα)] in stored sera from three collections (study baseline,+1 year, and+5 years) among 28 randomly selected PLCO participants were measured using a high-sensitivity Luminex xMap-based multiplex panel. Within- and between-subject components of variance were estimated from random effects models and were used to calculate the coefficient of variation (CV) and intraclass correlation coefficient (ICC) for analytes with <30% of samples below the limit of detection (LOD). Spearman correlation coefficients between measurements of the same analyte over time and between analytes were also calculated. RESULTS: Among the six cytokines with <30% of samples below the LOD, we observed excellent reproducibility for IL-6, IL-7, IL-13, and TNFα (ICC≥0.73), and fair to good reproducibility for IL-8 (ICC=0.55) and IL-10 (ICC=0.60). Spearman correlation coefficients comparing paired measurements of each cytokine at baseline and at +5 years were high (ρ≥0.74) with the exception of IL-10 (ρ=0.44). CONCLUSIONS: These results suggest that measurements of most of the cytokines evaluated in this study were highly reproducible over five-year periods. Published by Elsevier Ltd.
Authors: Yian Gu; Roy E Shore; Alan A Arslan; Karen L Koenig; Mengling Liu; Sherif Ibrahim; Anna E Lokshin; Anne Zeleniuch-Jacquotte Journal: Cancer Causes Control Date: 2010-04-07 Impact factor: 2.506
Authors: Jonathan N Hofmann; Kai Yu; Ronald L Horst; Richard B Hayes; Mark P Purdue Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-03-23 Impact factor: 4.254
Authors: Gloria Y F Ho; Xiao-Nan Xue; Robert D Burk; Robert C Kaplan; Elaine Cornell; Mary Cushman Journal: Cytokine Date: 2005-04-07 Impact factor: 3.861
Authors: Yian Gu; Anne Zeleniuch-Jacquotte; Faina Linkov; Karen L Koenig; Mengling Liu; Lyudmila Velikokhatnaya; Roy E Shore; Adele Marrangoni; Paolo Toniolo; Anna E Lokshin; Alan A Arslan Journal: Cytokine Date: 2008-12-05 Impact factor: 3.861
Authors: Robert C Kaplan; Gloria Y F Ho; XiaoNan Xue; Swapnil Rajpathak; Mary Cushman; Thomas E Rohan; Howard D Strickler; Philipp E Scherer; Kathryn Anastos Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-06 Impact factor: 4.254
Authors: Ilir Agalliu; Xiaonan Xue; Mary Cushman; Elaine Cornell; Ann W Hsing; Robert C Kaplan; Kathryn Anastos; Swapnil Rajpathak; Gloria Y F Ho Journal: Results Immunol Date: 2013-08-05
Authors: John Gubatan; Shuji Mitsuhashi; Maria Serena Longhi; Talia Zenlea; Laura Rosenberg; Simon Robson; Alan C Moss Journal: Cytokine Date: 2018-01-08 Impact factor: 3.861
Authors: Heather S McKay; Joseph B Margolick; Otoniel Martínez-Maza; Joseph Lopez; John Phair; Giovanna Rappocciolo; Thomas N Denny; Larry I Magpantay; Lisa P Jacobson; Jay H Bream Journal: Cytokine Date: 2016-12-09 Impact factor: 3.861
Authors: Mara M Epstein; Elizabeth Crabb Breen; Larry Magpantay; Roger Detels; Lauren Lepone; Sudhir Penugonda; Jay H Bream; Lisa Paula Jacobson; Otoniel Martínez-Maza; Brenda M Birmann Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-08-27 Impact factor: 4.254
Authors: Yuri Miyamoto; Jennifer Morozink Boylan; Christopher L Coe; Katherine B Curhan; Cynthia S Levine; Hazel Rose Markus; Jiyoung Park; Shinobu Kitayama; Norito Kawakami; Mayumi Karasawa; Gayle D Love; Carol D Ryff Journal: Brain Behav Immun Date: 2013-07-31 Impact factor: 7.217
Authors: Sandi L Navarro; Theodore M Brasky; Yvonne Schwarz; Xiaoling Song; C Y Wang; Alan R Kristal; Mario Kratz; Emily White; Johanna W Lampe Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-05-07 Impact factor: 4.254
Authors: Sheetal Hardikar; Xiaoling Song; Mario Kratz; Garnet L Anderson; Patricia L Blount; Brian J Reid; Thomas L Vaughan; Emily White Journal: Cancer Causes Control Date: 2014-05-17 Impact factor: 2.506
Authors: Lauren C Peres; Mary K Townsend; Brenda M Birmann; Jose R Conejo-Garcia; Yongjoo Kim; Laura D Kubzansky; Larry I Magpantay; Otoniel Martinez-Maza; Shelley S Tworoger Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-02-09 Impact factor: 4.254